MetaADEDB 2.0 @ LMMD
hydrochlorothiazide, losartan drug combination
(XRKMYXDEMOEFBN-UHFFFAOYSA-N)
Structure
SMILES
Clc1cc2NCNS(=O)(=O)c2cc1S(=O)(=O)N.CCCCc1nc(c(n1Cc1ccc(cc1)c1ccccc1c1[n-]nnn1)CO)Cl.[K+]
Molecular Formula:
C29H30Cl2KN9O5S2
Molecular Weight:
758.740
Log P:
6.8733
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
4
TPSA:
224.73
CAS Number(s):
156154-37-9
Synonym(s)
1.
hydrochlorothiazide, losartan drug combination
2.
Hyzaar
3.
Preminent
4.
hydrochlorothiazide - losartan
5.
hydrochlorothiazide - losartan potassium
6.
hydrochlorothiazide, losartan potassium drug combination
External Link(s)
MeSHC505809
PubChem Compound24783652
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Product substitution issueFAERS: 26US FAERS
2Drug ineffectiveFAERS: 24US FAERS
3HeadacheFAERS: 14US FAERS
4Feeling abnormalFAERS: 9US FAERS
5DizzinessFAERS: 8US FAERS
6MalaiseFAERS: 7US FAERS
7Product quality issueFAERS: 7US FAERS
8DysgeusiaFAERS: 5US FAERS
9Joint swellingFAERS: 5US FAERS
10Adverse eventFAERS: 4US FAERS
11AstheniaFAERS: 4US FAERS
12Blood pressure fluctuationFAERS: 4US FAERS
13FatigueFAERS: 4US FAERS
14Lip swellingFAERS: 4US FAERS
15NauseaFAERS: 4US FAERS
16PainFAERS: 4US FAERS
17PruritusFAERS: 4US FAERS
18PsoriasisFAERS: 4US FAERS
19SyncopeFAERS: 4US FAERS
20UrticariaFAERS: 4US FAERS
21AngioedemaFAERS: 3US FAERS
22Apparent deathFAERS: 3US FAERS
23ArthralgiaFAERS: 3US FAERS
24Blood potassium decreasedFAERS: 3US FAERS
25Cardiac ArrestFAERS: 3US FAERS
26Chest PainFAERS: 3US FAERS
27ErythemaFAERS: 3US FAERS
28HypotensionFAERS: 3US FAERS
29NervousnessFAERS: 3US FAERS
30PalpitationsFAERS: 3US FAERS
31SwellingFAERS: 3US FAERS
32TinnitusFAERS: 3US FAERS
33Abdominal PainFAERS: 2US FAERS
34Back PainFAERS: 2US FAERS
35Blood pressure inadequately controlledFAERS: 2US FAERS
36DehydrationFAERS: 2US FAERS
37DiplopiaFAERS: 2US FAERS
38Eye painFAERS: 2US FAERS
39FlushingFAERS: 2US FAERS
40FractureFAERS: 2US FAERS
41Gastric ulcerFAERS: 2US FAERS
42Medication residueFAERS: 2US FAERS
43Metabolic acidosisFAERS: 2US FAERS
44Musculoskeletal discomfortFAERS: 2US FAERS
45Musculoskeletal stiffnessFAERS: 2US FAERS
46MyalgiaFAERS: 2US FAERS
47Myocardial InfarctionFAERS: 2US FAERS
48Peripheral swellingFAERS: 2US FAERS
49Product physical issueFAERS: 2US FAERS
50Product taste abnormalFAERS: 2US FAERS
51RestlessnessFAERS: 2US FAERS
52Squamous cell carcinoma of skinFAERS: 2US FAERS
53TachycardiaFAERS: 2US FAERS
54Unevaluable eventFAERS: 2US FAERS
55Abdominal discomfortFAERS: 1US FAERS
56Actinic keratosisFAERS: 1US FAERS
57AlopeciaFAERS: 1US FAERS
58Altered state of consciousnessFAERS: 1US FAERS
59AmnesiaFAERS: 1US FAERS
60Angle Closure GlaucomaFAERS: 1US FAERS
61Autoimmune thyroiditisFAERS: 1US FAERS
62Basal cell carcinomaFAERS: 1US FAERS
63Blood creatine increasedFAERS: 1US FAERS
64Blood glucose increasedFAERS: 1US FAERS
65Blood sodium decreasedFAERS: 1US FAERS
66Bone painFAERS: 1US FAERS
67CataractFAERS: 1US FAERS
68Cerebral InfarctionFAERS: 1US FAERS
69Chest discomfortFAERS: 1US FAERS
70ConstipationFAERS: 1US FAERS
71CryotherapyFAERS: 1US FAERS
72DementiaFAERS: 1US FAERS
73Depressed Level of ConsciousnessFAERS: 1US FAERS
74DiplegiaFAERS: 1US FAERS
75Double stranded DNA antibody positiveFAERS: 1US FAERS
76Drug dispensing errorFAERS: 1US FAERS
77Drug dose omissionFAERS: 1US FAERS
78Drug level above therapeuticFAERS: 1US FAERS
79DyspepsiaFAERS: 1US FAERS
80EnterocolitisFAERS: 1US FAERS
81Flat affectFAERS: 1US FAERS
82FlatulenceFAERS: 1US FAERS
83Gait inabilityFAERS: 1US FAERS
84General physical health deteriorationFAERS: 1US FAERS
85Heat illnessFAERS: 1US FAERS
86HemiplegiaFAERS: 1US FAERS
87HypersensitivityFAERS: 1US FAERS
88Hypertensive crisisFAERS: 1US FAERS
89Increased upper airway secretionFAERS: 1US FAERS
90Joint warmthFAERS: 1US FAERS
91LacerationFAERS: 1US FAERS
92LymphomaFAERS: 1US FAERS
93Medication ErrorFAERS: 1US FAERS
94MeningiomaFAERS: 1US FAERS
95Multiple SclerosisFAERS: 1US FAERS
96Musculoskeletal PainFAERS: 1US FAERS
97Nephrotic SyndromeFAERS: 1US FAERS
98Oropharyngeal painFAERS: 1US FAERS
99OverdoseFAERS: 1US FAERS
100Pain of skinFAERS: 1US FAERS
101PancytopeniaFAERS: 1US FAERS
102Papillary serous endometrial carcinomaFAERS: 1US FAERS
103PemphigusFAERS: 1US FAERS
104Platelet count abnormalFAERS: 1US FAERS
105PolyarthritisFAERS: 1US FAERS
106Product container seal issueFAERS: 1US FAERS
107Product dose omissionFAERS: 1US FAERS
108Product label issueFAERS: 1US FAERS
109Product residue presentFAERS: 1US FAERS
110Product tamperingFAERS: 1US FAERS
111Pulmonary EmbolismFAERS: 1US FAERS
112Reaction to drug excipientsFAERS: 1US FAERS
113Recalled product administeredFAERS: 1US FAERS
114Respiratory FailureFAERS: 1US FAERS
115Respiratory distressFAERS: 1US FAERS
116RhabdomyolysisFAERS: 1US FAERS
117SinusitisFAERS: 1US FAERS
118Squamous cell carcinomaFAERS: 1US FAERS
119Suicide attemptFAERS: 1US FAERS
120Therapeutic response unexpectedFAERS: 1US FAERS
121Throat irritationFAERS: 1US FAERS
122TremorFAERS: 1US FAERS
123Vein wall hypertrophyFAERS: 1US FAERS
124Visual ImpairmentFAERS: 1US FAERS
125VomitingFAERS: 1US FAERS
126Weight decreasedFAERS: 1US FAERS
127WheezingFAERS: 1US FAERS
128White blood cell count decreasedFAERS: 1US FAERS
129Wrong technique in drug usage processFAERS: 1US FAERS
130Wrong technique in product usage processFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.